Latest clinical trial News | Page 4

Study shows ultra-low-dose 4-in-1 blood pressure pill would be cost-effective in Australia
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
Dimerix updates on expected timing of DMX-200 Phase 3 kidney trial outcome
Monash expert: New Nature Medicine study into the use of psychedelic substance, psilocybin, for the treatment of anorexia nervosa
One pill doesn’t fit all: cholesterol study reveals effects on lung function and brain size
Ketamine effective for treatment-resistant depression: clinical trial
Researchers look to arrest the development of Type 1 diabetes in children More children are getting Type 1 diabetes and Mater Researcher…
$5.5 million for research to reduce impact of loneliness on chronic disease
Sleep for bushfire survivors. Cane waste to rebuild soil health. The real carbon cost of your travel. Creating tri-sector careers
First cohort dosed in RECCE 327 rapid infusion UTI clinical trial
Ludwig Cancer Research study shows tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
Improving patient outcomes for kidney transplants
Major funding boost for phage therapy manufacturing in NSW
New data supports current management of CO2 levels in cardiac arrest patients
Update on MDMA and psilocybin access and safeguards from 1 July 2023
Trial finds vitamin D supplements could prevent heart attacks in over 60s
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
New psychedelic-assisted therapy trial aims to help cancer patients
Putting research in frame
Award-winning therapy brings light into darkness
Major Boost Into Childhood Cancer Research
Emerging health and medical research leaders are solving health problems and improving health care
PreBabe trial examines benefits of losing weight preconception
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
ARC Research Hub to transform biopharmaceutical manufacturing
Aravax launches new Phase 2 trial of peanut allergy candidate
The economics of it just won’t work – and it’ll be terrible for the environment: Australia’s leading expert on cell-based meat speaks…
World-first trial for paediatric brain cancer right here in NSW
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
The FDA finally approved Elon Musk’s Neuralink chip for human trials. Have all the concerns been addressed?
Benefits of creatine: safer birth for mum and baby
Financial boost for life-saving transplant treatment in WA
Existing drugs could treat strokes linked to dementia
New life changing treatment for dwarfism added to pbs
Avecho Biotechnology commences manufacturing for Phase 3 insomnia study
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
Trial of Android artificial pancreas system for adults with type 1 diabetes
Chimeric Therapeutics announces new capital raise
Engineers building tools to improve quality, production of disease-fighting cells
Mater Research leads in palliative care oncology research
CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
Human medicine may provide key to curing canine cancer
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
Statewide pharmacy prescribing trial to begin
NSW latest statewide pharmacy prescribing trial to begin
HIV patients fare well with mpox treatment
Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
GlyNAC supplementation improves cognitive decline and brain health in aging